David Dexter (Sentara Vascular Specialists, Norfolk, USA) analyses the state of the replacement venous valve space in the aftermath of the setback that saw the promising VenoValve surgical replacement device (Envveno Medical) fail to gain US Food and Drug Administration (FDA) approval. Watch the full interview here.











